I do hope so.
Why the poison pill 2 years ago ? . shows that they knew they are a target.
taking it to fda approval without a buyout / partnership
in this time , multiple markets are open for cpulse2
cpulse 2 development
last offering was 10.5 , reason we fell from these highs was the slow enrollment trial start.
the pause ofcourse was a kick in the balls and the time it took for reactivation took us from 4s to 1
has the technology changed ? is their a competitor ? no
finance situation / enrollments
finance : debt ammended . 8 months of cash ? why would svb agree unless they know something is in the offing. the company has 2 options , major dilution at these levels ( they lose out the most ) or a partnership or us distribution rights or a license deal. that would give us enough money to last 2016.
have an offering of 6-7m shares when the stock is $6-10
enrollments : 40 sites soon to be all activated. the only way is up
cpulse2 : talks with the fda to fast track approval
-----------------------------------------------------------------------------------------------------------
but the questions are
1- why are we at $1 and no major buying
2- why is the company silent 3 weeks after ceo sudden departure
3- how are we valued at $24m ?
4- till when will we have positive news and the stock drops ( debt ammendment )
5- 91% down since nasdaq inception.
are we the only ones who see the potential ?
is there something hidden which explains the death of the stock
we sound like a broken cd , but the more these questions are left un answered , the further we will drop
the more we drop , the harder it will be for the company to achieve its goals.
Add to My Watchlist
What is My Watchlist?